AAAAAA
Results: 26-50/119
Authors:
HEINEMANN V
KAHNY B
JEHN U
MUHLBAYER D
DEBUS A
WACHHOLZ K
BOSSE D
KOLB HJ
WILMANNS W
Citation: V. Heinemann et al., SERUM PHARMACOLOGY OF AMPHOTERICIN-B APPLIED IN LIPID EMULSIONS, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 728-732
Authors:
KOLB HJ
GUNTHER W
SCHUMM M
HOLLER E
WILMANNS W
THIERFELDER S
Citation: Hj. Kolb et al., ADOPTIVE IMMUNOTHERAPY IN CANINE CHIMERAS, Transplantation, 63(3), 1997, pp. 430-436
Authors:
GRAEFF H
WILMANNS W
JANICKE F
SAUER H
CLASSEN S
Citation: H. Graeff et al., PROGNOSTIC AND THERAPEUTIC FACTORS IN BRE AST-CANCER - RESULTS OF A CONSENSUS CONFERENCE, Geburtshilfe und Frauenheilkunde, 57(8), 1997, pp. 143-146
Authors:
MUNKER R
FLEISCHER R
FALK M
MULTHOFF G
WILMANNS W
Citation: R. Munker et al., RETINOIDS INDUCE CD95 FAS IN LEUKEMIA AND LYMPHOMA-CELLS/, Blood, 90(10), 1997, pp. 3929-3929
Authors:
GUENTHER C
HOLLER E
MUTH A
LEDDEROSE G
HAHN J
THOMSSEN C
EICHHORN P
WICK M
ROECKEN M
PLEWIG G
WILMANNS W
KOLB HJ
Citation: C. Guenther et al., INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 4405-4405
Authors:
GERHARTZ HH
SCHWENKE H
BAZARBASHI S
THIEL E
BLAU W
HUHN D
HEIMPEL H
BROWN P
SCHLIEMOK G
ILLIGER HJ
WALTHER J
WILMANNS W
CHARISSE G
FARBER L
HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/, Blood, 90(10), 1997, pp. 1731-1731
Authors:
ENGELHARD M
BRITTINGER G
HUHN D
GERHARTZ HH
MEUSERS P
SIEGERT W
THIEL E
WILMANNS W
AYDEMIR U
BIERWOLF S
GRIESSER H
TIEMANN M
LENNERT K
Citation: M. Engelhard et al., SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - DISTINCTION OF CENTROBLASTIC AND IMMUNOBLASTIC LYMPHOMAS IS A SIGNIFICANT PROGNOSTIC RISK FACTOR, Blood, 89(7), 1997, pp. 2291-2297
Authors:
SALAT C
HOLLER E
KOLB HJ
REINHARDT B
PIHUSCH R
WILMANNS W
HILLER E
Citation: C. Salat et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 CONFIRMS THE DIAGNOSIS OF HEPATIC VENOOCCLUSIVE DISEASE IN PATIENTS WITH HYPERBILIRUBINEMIA AFTER BONE-MARROW TRANSPLANTATION, Blood, 89(6), 1997, pp. 2184-2188
Authors:
GERL A
WILMANNS W
Citation: A. Gerl et W. Wilmanns, MEDICAL DIFFERENTIAL-DIAGNOSIS OF LOW-BAC K-PAIN, Deutsche Medizinische Wochenschrift, 121(15), 1996, pp. 499-499
Authors:
GERL A
LAMERZ R
CLEMM C
MANN K
HARTENSTEIN R
WILMANNS W
Citation: A. Gerl et al., DOES SERUM TUMOR-MARKER HALF-LIFE COMPLEMENT PRETREATMENT RISK STRATIFICATION IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, Clinical cancer research, 2(9), 1996, pp. 1565-1570
Authors:
GERL A
WILMANNS W
Citation: A. Gerl et W. Wilmanns, ANTITUMOR-ACTIVITY OF PACLITAXEL AFTER FAILURE OF HIGH-DOSE CHEMOTHERAPY IN A PATIENT WITH LATE RELAPSE OF A NONSEMINOMATOUS GERM-CELL TUMOR, Anti-cancer drugs, 7(6), 1996, pp. 716-718
Authors:
STOETZER OJ
NUSSLER V
DARSOW M
GULLIS E
PELKAFLEISCHER R
SCHEEL U
WILMANNS W
Citation: Oj. Stoetzer et al., ASSOCIATION OF BCL-2, BAX, BCL-XL AND INTEULEUKIN-1-BETA-CONVERTING ENZYME EXPRESSION WITH INITIAL RESPONSE TO CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA, Leukemia, 10, 1996, pp. 18-22
Authors:
NUSSLER V
PELKAFLEISCHER R
ZWIERZINA H
NERL C
BECKERT B
GIESELER F
DIEM H
LEDDEROSE G
GULLIS E
SAUER H
WILMANNS W
Citation: V. Nussler et al., P-GLYCOPROTEIN EXPRESSION IN PATIENTS WITH ACUTE-LEUKEMIA - CLINICAL RELEVANCE, Leukemia, 10, 1996, pp. 23-31
Authors:
ERTL B
ALBIEZ M
RUSTIGE E
KOLB HJ
WILMANNS W
HOLLER E
Citation: B. Ertl et al., DYSREGULATED MATURATION AND TNF-ALPHA-PRODUCTION OF MACROPHAGES IN AML-PATIENTS ADMITTED TO ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of leukocyte biology, 1996, pp. 70-70
Authors:
MUNKER R
STOTZER O
DARSOW M
CLASSEN S
LEBEAU A
WILMANNS W
Citation: R. Munker et al., AUTOANTIBODIES AGAINST P53 ARE NOT INCREASED IN HUMAN ASCITES AND PLEURAL EFFUSIONS, Cancer immunology and immunotherapy, 42(3), 1996, pp. 200-201
Authors:
MITTERMUELLER J
ISSELS RD
UBERFUHR P
POTSCHER C
FUCHS A
MENZEL H
SCHULZE C
KOLB HJ
REICHART B
WILMANNS W
Citation: J. Mittermueller et al., PRIMARY CARDIAC SARCOMA TREATED WITH CHEMOTHERAPY, HEART-TRANSPLANTATION AND PERIPHERAL STEM-CELL TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 110-110
Authors:
DUELL T
SCHALHORN A
POTSCHER C
HABERL C
BEYKIRCH M
PFISTER W
WILMANNS W
Citation: T. Duell et al., A 54-YEAR-OLD SERIOUSLY ILL MALE-PATIENT WITH DIFFUSE PAIN SYNDROME, PERIPHERIAL FACIAL PARESIS AND PROGRESSIVE TETRAPARESIS, Der Internist, 37(8), 1996, pp. 839-843
Authors:
GERL A
CLEMM C
LAMERZ R
WILMANNS W
Citation: A. Gerl et al., CISPLATIN-BASED CHEMOTHERAPY OF PRIMARY EXTRAGONADAL GERM-CELL TUMORS- A SINGLE INSTITUTION EXPERIENCE, Cancer, 77(3), 1996, pp. 526-532
Authors:
GERL A
CLEMM C
SCHMELLER N
HARTENSTEIN R
LAMERZ R
WILMANNS W
Citation: A. Gerl et al., ADVANCES IN THE MANAGEMENT OF METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS DURING THE CISPLATIN ERA - A SINGLE-INSTITUTION EXPERIENCE, British Journal of Cancer, 74(8), 1996, pp. 1280-1285
Authors:
HILL W
HOLLER E
SCHLEUNING M
SCHMID M
MUTH A
HILL C
KOLB HJ
WILMANNS W
Citation: W. Hill et al., AVASCULAR NECROSIS OF BONE AFTER BONE-MARROW TRANSPLANTATION - INCIDENCE, CLINICAL FINDINGS AND RISK-FACTORS, Blood, 88(10), 1996, pp. 1039-1039
Authors:
SCHMETZER HM
WILMANNS W
GERHARTZ HH
Citation: Hm. Schmetzer et al., DETECTION OF ACUTE MYELOID LEUKEMIC-CELLS IN COMPLETE REMISSION AND IN EXTRAMEDULLARY SITES BY CLONAL ANALYSES, Acta haematologica, 96(2), 1996, pp. 83-87
Authors:
GERL A
WEIGL P
GASSEL WD
WILMANNS W
Citation: A. Gerl et al., MYOCARDIAL-INFARCTION AFTER ADJUVANT CHEMOTHERAPY FOR RESECTED STAGE-II NONSEMINOMATOUS TESTICULAR CANCER, Oncology Reports, 2(6), 1995, pp. 1097-1099
Authors:
DENZLINGER C
HABERL C
WILMANNS W
Citation: C. Denzlinger et al., CYSTEINYL LEUKOTRIENE PRODUCTION IN ANAPHYLACTIC REACTIONS, International archives of allergy and immunology, 108(2), 1995, pp. 158-164
Authors:
NUSSLER V
PELKAFLEISCHER R
ZWIERZINA H
NERL C
GIESELER F
GULLIS E
BECKERT B
HOLZEL D
LEDDEROSE G
SAUER H
WILMANNS W
Citation: V. Nussler et al., CLINICAL RELEVANCE OF P-GLYCOPROTEIN-RELATED RESISTANCE IN PATIENTS WITH ACUTE-LEUKEMIA, European journal of cancer, 31A, 1995, pp. 131-131
Authors:
HILL W
MUNKER R
STOTZER O
DARSOW M
JEHN U
WILMANNS W
Citation: W. Hill et al., IMMUNOHISTOCHEMICAL EVIDENCE OF CYTOPLASMIC AND INTERSTITIAL TRANSFORMING GROWTH-FACTOR BETA-3 (TGF-BETA) IN MYELOPROLIFERATIVE DISEASES (MPD), European journal of cancer, 31A, 1995, pp. 240-240